Abstract

BackgroundThe tumor immune microenvironment has become the focus of research in clear cell renal cell carcinoma (ccRCC) due to its important role in immune surveillance post nephrectomy. This study investigates the correlation of tumor infiltrating immune cell characteristics with rates of recurrence following surgery in localized ccRCC.MethodsWe morphologically identified and scored tumor infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) stained slides of patients with localized ccRCC (stage ≥T1b excluding stage IV). The University of Alabama at Birmingham (UAB) dataset (n = 159) was used to discover and the Fox Chase Cancer Center (FCCC) dataset (n = 198) was used to validate the results of morphologic immune cell analysis. We then performed gene expression analysis using the Immune Profile panel by NanoString in the UAB cohort and identified immune cells and pathways associated with recurrence, followed by validation in the Cancer Genome Atlas (TCGA) ccRCC dataset. Infiltrating immune cell types were identified by gene expression deconvolution.ResultsThe presence of TILs identified by morphology correlated with higher T cell, Th1, CD8+ T and Treg gene signatures. Recurrence was associated with lower T cells and higher neutrophils. Higher Teffector (Teff)/Treg ratio correlated with lower rate of recurrence and was validated in the TCGA dataset. Genes associated with adaptive immune response were downregulated in tumors that recurred. Unsupervised hierarchical clustering identified a subset of patients with over-expression of adaptive response genes including CD8, CD3, GZMA/B, PRF1, IDO1, CTLA4, PDL1, ICOS and TIGIT. These patients had higher morphologic lymphocyte infiltration and T cell gene expression. Higher levels of TILs identified by morphology correlated with higher rates of recurrence in our discovery dataset but not in our validation set.ConclusionsRecurrence of ccRCC following surgery was associated with lower T cell infiltrate, lower adaptive immune response and higher neutrophil gene expression. Presence of higher Teff/Treg ratio correlated with lower recurrence.

Highlights

  • The tumor immune microenvironment has become the focus of research in clear cell renal cell carcinoma due to its important role in immune surveillance post nephrectomy

  • Studies describing the prognostic impact of intra-tumoral immune cell infiltrates on recurrence in patients with localized renal cell carcinoma (RCC) have produced conflicting results

  • Patient selection We employed a discovery sample set from the University of Alabama at Birmingham (UAB) and separate validation sample set from Fox Chase Cancer Center (FCCC) for morphologic tumor infiltrating lymphocytes (TILs) evaluation

Read more

Summary

Introduction

The tumor immune microenvironment has become the focus of research in clear cell renal cell carcinoma (ccRCC) due to its important role in immune surveillance post nephrectomy. 30–40% of patients with localized clear cell renal cell carcinoma (ccRCC) develop metastatic recurrence during follow-up after surgical resection. Studies describing the prognostic impact of intra-tumoral immune cell infiltrates (lymphocytes, plasma cells, macrophages, neutrophils) on recurrence in patients with localized renal cell carcinoma (RCC) have produced conflicting results. Choueiri and Remark et al reported that the presence of increased CD8+ T cells was associated with shorter survival in metastatic RCC patients [7, 8]. Another study reported that the presence of CD8 + T cells is associated with better survival in localized RCC [9]. In a retrospective analysis of the S-TRAC trial using adjuvant sunitinib in high risk RCC patients, higher tumor infiltration of CD8+ T cells was associated with longer disease-free survival in the sunitinib arm [1]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call